DUSP13 antibody
Principal name
DUSP13 antibody
Alternative names for DUSP13 antibody
Dual specificity phosphatase SKRP4, TMDP, Dual specificity protein phosphatase 13, Testis- and skeletal-muscle-specific DSP
Ncbi ID
NP_057448, 9606, NP_001007272.1, NP_038877.2, NM_013849, NM_001007268, NM_016364, NM_001007272, NM_001007271, NM_001007273
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of DUSP13 antibody
- Kit Component:
- - KN304866G1, Dusp13 gRNA vector 1 in pCas-Guide vector
- KN304866G2, Dusp13 gRNA vector 2 in pCas-Guide vector
- KN304866D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Chen H.-H., et al. (2004) J. Biol. Chem. 279:41404-41413Katagiri C, et al. (2011) Mol Cell Biochem. 352(1-2):155-62.
Western blot analysis of DUSP13 in human skeletal muscle lysate in the 1 ) absence and 2 ) presence of immunizing peptide. Using DUSP13 polyclonal antibody ( Cat # PAB0294 ) at 0.5 µg/ml.
Western blot analysis of DUSP13 in human skeletal muscle lysate in the 1 ) absence and 2 ) presence of immunizing peptide. Using DUSP13 polyclonal antibody ( Cat # PAB0295 ) at 0.5 µg/ml.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with DUSP13 polyclonal antibody ( Cat # PAB4140 ) , which was peroxidase-conjugated to the secondary antibody, followed by AEC staining.This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
The DUSP13 polyclonal antibody ( Cat # PAB4140 ) is used in Western blot to detect DUSP13 in human CEM cell lysate.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining
Western blot analysis of DUSP13 (arrow) using DUSP13-M1 Antibody (N-term). 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the DUSP13 gene (Lane 2) (Origene Technologies).
WB Suggested Anti-DUSP13 Antibody; Titration: 1.0 ug/ml; Positive Control: Fetal Lung
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using (DUSP13 Antibody) at dilution 1/60, on the right is treated with fusion protein. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human brain tissue using (DUSP13 Antibody) at dilution 1/60, on the right is treated with fusion protein. (Original magnification: ×200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA331323 | DUSP13 antibody |
||||||
| Rabbit Polyclonal Anti-DUSP13 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Hu, Ms, Rb, Rt | WB |
0.1 ml /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA349310 | DUSP13 antibody |
||||||
| Rabbit Polyclonal Anti-DUSP13 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| AP15276PU-N | DUSP13 (N-term) antibody |
||||||
 |
Rabbit | Ig | Purified | Hu | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP303085 | DUSP13 (transcript variant 6) |
||||
| Recombinant protein of human dual specificity phosphatase 13 (DUSP13), transcript variant 6 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| AR50478PU-N | DUSP13 (1-198, His-tag) |
||||
 |
Human | Purified | > 95 % by SDS - PAGE | E. coli |
0.25 mg /
€1,070.00
|
| OriGene Technologies GmbH | |||||
| AR50478PU-S | DUSP13 (1-198, His-tag) |
||||
|
Human | Purified | > 95 % by SDS - PAGE | E. coli |
50 µg /
€400.00
|
| OriGene Technologies GmbH | |||||
Human Lenti ORF Particles
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR219056L2V | Lenti ORF particles, Dusp13 (GFP-tagged) - Mouse dual specificity phosphatase 13 (Dusp13), transcript variant 1, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR218320L2V | Lenti ORF particles, Dusp13 (GFP-tagged) - Mouse dual specificity phosphatase 13 (Dusp13), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR219056L1V | Lenti ORF particles, Dusp13 (Myc-DDK-tagged) - Mouse dual specificity phosphatase 13 (Dusp13), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR218320L1V | Lenti ORF particles, Dusp13 (Myc-DDK-tagged) - Mouse dual specificity phosphatase 13 (Dusp13), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
